High estrogen in males most often results from excess body fat, which actively converts testosterone into estrogen. The typical estradiol level in men falls between 10 and 40 pg/mL, and levels above roughly 42 pg/mL are considered elevated. In a large study of over 34,000 men being treated for low testosterone, about 1 in 5 had high estradiol. The causes range from common and reversible factors like weight gain and medications to less common ones like liver disease and hormone-producing tumors.
How Body Fat Drives Estrogen Up
Fat tissue isn’t just storage. It’s metabolically active, and one of the things it does is produce an enzyme called aromatase. This enzyme takes testosterone circulating in your blood and converts it into estrogen. The more fat tissue you carry, the more aromatase you produce, and the more testosterone gets rerouted into estrogen. This creates a frustrating cycle: higher estrogen promotes further fat accumulation, particularly around the midsection, which in turn increases aromatase activity even more.
This mechanism is the single most common driver of elevated estrogen in men. It also explains why men with obesity frequently have both low testosterone and high estrogen at the same time. Losing body fat directly reduces the amount of aromatase available to make this conversion, which is why weight loss alone can meaningfully shift the testosterone-to-estrogen ratio back toward normal.
Testosterone Replacement Therapy
This one catches many men off guard. Testosterone replacement therapy (TRT) is meant to fix low testosterone, but adding more testosterone to your system also gives aromatase more raw material to work with. The result is that estrogen levels can climb alongside testosterone levels, sometimes high enough to cause breast tissue growth or tenderness.
The risk is higher with larger doses and with certain formulations that cause sharper spikes in testosterone levels. Management typically involves adjusting the dose, switching to a formulation that produces more stable blood levels, or in some cases adding a medication that blocks aromatase activity. Current guidelines from the American Urological Association recommend checking estradiol levels before starting TRT if a man has breast symptoms, and monitoring for breast changes during treatment.
Liver Disease and Estrogen Clearance
Your liver is responsible for breaking down about 70% of the sex hormones in your body. When the liver is damaged, particularly in cirrhosis, this clearance process slows dramatically. At the same time, liver disease increases aromatase activity and shifts blood flow in ways that boost the peripheral conversion of testosterone into estrogen. The combination of producing more estrogen and clearing less of it leads to a significant hormonal imbalance.
Chronic liver disease also raises levels of a protein called sex hormone-binding globulin, which binds to testosterone and makes it unavailable. So men with cirrhosis often end up with both less usable testosterone and more circulating estrogen. Visible signs like breast enlargement and changes in body hair distribution are common in advanced liver disease for exactly this reason.
Medications That Raise Estrogen
Several commonly prescribed drugs can shift the hormonal balance toward estrogen, either by directly increasing estrogen levels, interfering with testosterone production, or blocking how testosterone works in the body. The medications most clearly linked to this effect include:
- Spironolactone, a blood pressure and heart failure drug that also blocks androgen receptors
- Cimetidine, an older heartburn medication
- Ketoconazole, an antifungal that suppresses testosterone production
- 5-alpha reductase inhibitors, used for hair loss and enlarged prostate
- Anti-androgens, used in prostate cancer treatment
Other medications probably contribute as well, including certain calcium channel blockers (verapamil, nifedipine), the antipsychotic risperidone, some HIV medications, opioids, and anabolic steroids. Alcohol, while not a prescription drug, acts through similar pathways and is a well-established contributor to estrogen elevation in men, especially with heavy or chronic use.
Aging and Shifting Hormone Ratios
As men age, the balance between testosterone and estrogen gradually shifts. Free testosterone declines, while aromatase activity increases. The net effect is that even though absolute estrogen levels may drop modestly with age, the ratio of free testosterone to free estrogen tilts toward estrogen. This relative shift can produce symptoms of estrogen excess even when estradiol levels on a blood test look technically normal. It also helps explain why older men are more likely to develop breast tissue growth and carry more abdominal fat.
Genetic Conditions
Klinefelter syndrome is the most well-known genetic cause. Men with this condition carry an extra X chromosome (47,XXY instead of the typical 46,XY), which affects testicular function starting around puberty. The testes remain small and underdeveloped, leading to low testosterone production and elevated levels of the pituitary hormones FSH and LH as the brain tries to compensate. Breast enlargement is one of the hallmark features described since the condition was first identified in 1942. Interestingly, while the hormonal disruption in Klinefelter syndrome is significant, only about 6% of men with the condition show frankly elevated estradiol on blood tests. The symptoms seem to be driven more by the very low testosterone than by dramatically high estrogen.
Hormone-Producing Tumors
Rarely, a tumor can directly secrete estrogen or produce excess testosterone that then gets converted into estrogen. Leydig cell tumors of the testis are the most common type in this category, though they still account for only about 1% of all adult testicular tumors. These tumors originate from the cells that normally produce testosterone, but their hormone output is unregulated and can include estrogen directly. About 20% of adult men with Leydig cell tumors develop breast enlargement. Adrenal tumors can cause a similar picture. The vast majority of Leydig cell tumors are benign, with only about 2.5% showing malignant behavior.
Environmental Estrogen Mimics
Certain synthetic chemicals can mimic estrogen in the body by binding to the same receptors that natural estrogen uses. These compounds, broadly called endocrine disruptors, are widespread in everyday products. The most studied include bisphenol A (BPA), found in the lining of canned foods and some plastic containers, and phthalates, used to make plastics flexible and found in flooring, packaging, and medical tubing. Older pesticides like DDT and industrial chemicals like PCBs also fall into this category.
Exposure happens mainly through food and drink, particularly from heated plastic containers or repeated use of polycarbonate bottles. BPA has confirmed estrogenic activity, and measurable levels have been detected in the majority of people tested. The practical impact on any individual man’s estrogen levels is harder to pin down than the effect of, say, body fat or a medication. But cumulative exposure to multiple endocrine disruptors over time is a recognized concern for male reproductive health, including effects on sperm quality and hormone balance. Reducing exposure means avoiding heating food in plastic, choosing fresh over canned foods when possible, and limiting contact with products known to contain phthalates.